Medical Research · FL
Max Planck Florida Corporation
Max Planck Florida Corporation reported paying David Fitzpatrick, Chief Executive Officer, $543,979 in total compensation (FY 2024).
That places David Fitzpatrick at approximately the 54th percentile among 24 similarly sized medical research nonprofits (median $474,370).
$33,505,675Total revenue (FY 2024)
$543,979Total executive compensation
54thPercentile vs. peers
Setting executive pay for this board?
Generate a board-ready comparability report for Max Planck Florida Corporation — named comparables, percentiles, methodology, and the 26 CFR 53.4958-6 minutes language a board can use toward the rebuttable presumption.
Build the comparability report →Comparable medical research nonprofits
Compensation is normalized to FL cost of living (BEA Regional Price Parities); each organization's reported figure is on its linked 990.
| Organization | State | Revenue | Total comp |
|---|---|---|---|
| Transcelerate Biopharma Inc | PA | $34,168,812 | $2,770,427 |
| Nrg Oncology Foundation Inc | PA | $32,205,558 | $16,337 |
| Wills Eye Ophthalmology | PA | $31,970,742 | $279,972 |
| Greenwood Genetic Center Inc | SC | $31,727,683 | $478,427 |
| American Urological Association | MD | $35,355,221 | $655,092 |
| Palo Alto Veterans Institute For | CA | $30,503,398 | $287,806 |
| Bliss Cares Inc | FL | $36,602,971 | $195,461 |
| The Foundation Fighting Blindness Inc | MD | $36,615,169 | $579,582 |